Jennie E. DeVore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jennie E. DeVore has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Felicity Muth
Department of Integrative Biology, University of Texas at Austin, Austin, USA
2 shared publications - Aalo B. Choudhary
University of Texas at Austin, Austin, Texas, UNITED STATES
1 shared publication - Chaeho Moon
Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA
1 shared publication - Chantal M. F. Gonzalez
Southwestern University Georgetown, TX. United States
1 shared publication - Claire T. Hemingway
Department of Ecology & Evolutionary Biology, University of Tennessee, Knoxville, USA
1 shared publication Dale J. Christensen
TFF Pharmaceuticals, Inc. Austin, TX 78746, USA
1 shared publication
Latest Publications
- Open Access
- 3 October 2026
- Published by Caltech Library in microPublication Biology
- No. 11
Transcriptomes of Nesting-Relevant Brain Regions Reflect Sex-Specific Roles During Nest Building in the Zebra Finch (Taeniopygia guttata)
- 3 October 2026
- Published by Caltech Library in microPublication Biology
- No. 11
Open AccessTranscriptomes of Nesting-Relevant Brain Regions Reflect Sex-Specific Roles During Nest Building in the Zebra Finch (Taeniopygia guttata)
- 11 August 2025
- Published by Springer Nature in Insectes Sociaux
- Vol. 73 (1) , 45-53
Bumblebees exposed to a novel ‘bee-safe’ insecticide have impaired alloparental care and reproductive output
- 11 August 2025
- Published by Springer Nature in Insectes Sociaux
- Vol. 73 (1) , 45-53
Bumblebees exposed to a novel ‘bee-safe’ insecticide have impaired alloparental care and reproductive output
- 18 September 2024
- Published by The Royal Society in Proceedings Of The Royal Society B-Biological Sciences
- Vol. 291 (2031) , 20240843
Economic foraging in a floral marketplace: asymmetrically dominated decoy effects in bumblebees
While most models of decision-making assume that individuals assign options absolute values, animals often assess options comparatively, violating principles of economic rationality. Such ‘irrational’ preferences are especially common when two rewards vary along multiple dimensions of quality and a third, ‘decoy’ option is available. Bumblebees are models of decision-making, yet whether they are subject to decoy effects is unknown. We addressed this question using bumblebees ( Bombus impatiens ) choosing between flowers that varied in their nectar concentration and reward rate. We first gave bees a choice between two flower types, one higher in concentration and the other higher in reward rate. Bees were then given a choice between these flowers and either a ‘concentration’ or ‘rate’ decoy, designed to be asymmetrically dominated on each axis. The rate decoy increased bees’ preference in the expected direction, while the concentration decoy did not. In a second experiment, we manipulated choices along two single reward dimensions to test whether this discrepancy was explained by differences in how concentration versus reward rate were evaluated. We found that low-concentration decoys increased bees’ preference for the medium option as predicted, whereas low-rate decoys had no effect. Our results suggest that both low- and high-value flowers can influence pollinator preferences in ways previously unconsidered.
- 18 September 2024
- Published by The Royal Society in Proceedings Of The Royal Society B-Biological Sciences
- Vol. 291 (2031) , 20240843
Economic foraging in a floral marketplace: asymmetrically dominated decoy effects in bumblebees
While most models of decision-making assume that individuals assign options absolute values, animals often assess options comparatively, violating principles of economic rationality. Such ‘irrational’ preferences are especially common when two rewards vary along multiple dimensions of quality and a third, ‘decoy’ option is available. Bumblebees are models of decision-making, yet whether they are subject to decoy effects is unknown. We addressed this question using bumblebees ( Bombus impatiens ) choosing between flowers that varied in their nectar concentration and reward rate. We first gave bees a choice between two flower types, one higher in concentration and the other higher in reward rate. Bees were then given a choice between these flowers and either a ‘concentration’ or ‘rate’ decoy, designed to be asymmetrically dominated on each axis. The rate decoy increased bees’ preference in the expected direction, while the concentration decoy did not. In a second experiment, we manipulated choices along two single reward dimensions to test whether this discrepancy was explained by differences in how concentration versus reward rate were evaluated. We found that low-concentration decoys increased bees’ preference for the medium option as predicted, whereas low-rate decoys had no effect. Our results suggest that both low- and high-value flowers can influence pollinator preferences in ways previously unconsidered.
- Open Access
In Vivo Pharmacokinetic Study of Remdesivir Dry Powder for Inhalation in Hamsters
Remdesivir dry powder for inhalation was previously developed using thin film freezing (TFF). A single-dose 24-hour pharmacokinetic study in hamsters, a small animal model for SARS-CoV-2, demonstrated that pulmonary delivery of TFF remdesivir can achieve plasma remdesivir and GS-441524 levels higher than the reported EC 50 s of both remdesivir and GS-441524 (in human epithelial cells) over 20 hours. The half-life of GS-4412524 following dry powder insufflation was about 7 hours, suggesting the dosing regimen would be twice daily administration. Although the remdesivir-Captisol ® (80/20 w/w) formulation showed faster and greater absorption of remdesivir and GS-4412524 in the lung, remdesivir-leucine (80/20 w/w) exhibited a greater C max with shorter T max and lower AUC of GS-441524, indicating lower total drug exposure is required to achieve a high effective concentration against SAR-CoV-2. In conclusion, remdesivir dry powder for inhalation would be a promising alternative dosage form for the treatment of COVID-19 disease.
Open AccessIn Vivo Pharmacokinetic Study of Remdesivir Dry Powder for Inhalation in Hamsters
Remdesivir dry powder for inhalation was previously developed using thin film freezing (TFF). A single-dose 24-hour pharmacokinetic study in hamsters, a small animal model for SARS-CoV-2, demonstrated that pulmonary delivery of TFF remdesivir can achieve plasma remdesivir and GS-441524 levels higher than the reported EC 50 s of both remdesivir and GS-441524 (in human epithelial cells) over 20 hours. The half-life of GS-4412524 following dry powder insufflation was about 7 hours, suggesting the dosing regimen would be twice daily administration. Although the remdesivir-Captisol ® (80/20 w/w) formulation showed faster and greater absorption of remdesivir and GS-4412524 in the lung, remdesivir-leucine (80/20 w/w) exhibited a greater C max with shorter T max and lower AUC of GS-441524, indicating lower total drug exposure is required to achieve a high effective concentration against SAR-CoV-2. In conclusion, remdesivir dry powder for inhalation would be a promising alternative dosage form for the treatment of COVID-19 disease.
- 1 February 2018
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 165, 36-44
The effects of ketamine on sexual behavior, anxiety, and locomotion in female rats
- 1 February 2018
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 165, 36-44
The effects of ketamine on sexual behavior, anxiety, and locomotion in female rats